Literature DB >> 13362140

Experimental studies on Rh immunization.

I DAVIDSOHN, L MASAITIS, K STERN.   

Abstract

Keywords:  RH FACTORS

Mesh:

Substances:

Year:  1956        PMID: 13362140     DOI: 10.1093/ajcp/26.8.833

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  16 in total

1.  THE FREQUENCY OF ABO-INCOMPATIBLE COMBINATIONS IN RELATION TO MATERNAL RHESUS ANTIBODY VALUES IN RH IMMUNIZED WOMEN.

Authors:  G H VOS
Journal:  Am J Hum Genet       Date:  1965-05       Impact factor: 11.025

2.  Experimental studies on the prevention of Rh haemolytic disease.

Authors:  R FINN; C A CLARKE; W T DONOHOE; R B McCONNELL; P M SHEPPARD; D LEHANE; W KULKE
Journal:  Br Med J       Date:  1961-05-27

3.  ABO-Rh interaction of an Rh-incompatibly mated population.

Authors:  B H COHEN
Journal:  Am J Hum Genet       Date:  1960-06       Impact factor: 11.025

4.  [Study of determination of ABO gene frequency by the maximum likehood method and other methods based on forensic blood group determinations in Berlin].

Authors:  W HELMBOLD; O PROKOP
Journal:  Blut       Date:  1958-08

5.  The destruction of red cells by antibodies in man. II. Pyrogenic, leukocytic and dermal responses to immune hemolysis.

Authors:  J H JANDL; A S TOMLINSON
Journal:  J Clin Invest       Date:  1958-08       Impact factor: 14.808

6.  The inhibiting effect of ABO incompatibility on Rh immunization in pregnancy; a statistical analysis of 1,742 families.

Authors:  J REEPMAKER; L E NIJENHUIS; J van LOGHEM
Journal:  Am J Hum Genet       Date:  1962-06       Impact factor: 11.025

7.  Platelet transfusion - the art and science of compromise.

Authors:  Joan Cid; Sarah K Harm; Mark H Yazer
Journal:  Transfus Med Hemother       Date:  2013-04-26       Impact factor: 3.747

8.  The history of rhesus prophylaxis with anti-D.

Authors:  A Wegmann; R Glück
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

9.  Regulation of the immune response. VI. Inability of F(ab') 2 antibody to terminate established immune responses and its ability to interfere with IgG antibody-mediated immunosuppression.

Authors:  P L Chan; N R Sinclair
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

10.  Prevention of Rh-haemolytic disease.

Authors:  C A Clarke
Journal:  Br Med J       Date:  1967-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.